Literature DB >> 8733791

Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.

C Brabbins1, J Butler, R Bentall.   

Abstract

BACKGROUND: The effects of neuroleptic medication on schizophrenic patients are both positive (reduction in symptoms) and negative (adverse side-effects). Given that altered cognitive functioning may be a feature of schizophrenia, the use of neuroleptics raises important ethical and legal issues.
METHOD: A selective review was carried out of papers addressing ethical arguments for and against obtaining consent from schizophrenic patients, and the ethical and legal requirements which must be met for consent to occur.
RESULTS: Although a balance must be met between arguments for and against obtaining consent, clinicians should seek informed consent in all but exceptional circumstances. Obtaining consent depends on the adequate presentation of information, the absence of duress and the patients' capacity to consent. Various tests of capacity to consent have been proposed.
CONCLUSIONS: It is proposed that clinicians employ a proforma to record attempts to obtain informed consent during routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733791     DOI: 10.1192/bjp.168.5.540

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Engaging the homeless paranoid patient.

Authors:  Brenda Roman; Gayatri Patel
Journal:  Psychiatry (Edgmont)       Date:  2007-07

2.  [Patient knowledge regarding tardive dyskinesia].

Authors:  E M Haberfellner; H Rittmannsberger
Journal:  Nervenarzt       Date:  2006-03       Impact factor: 1.214

3.  Incapacity to give informed consent owing to mental disorder.

Authors:  C W Van Staden; C Krüger
Journal:  J Med Ethics       Date:  2003-02       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.